NCT01780805

Brief Summary

This study involves completion of questionnaires, computer-based cognitive tasks and an alcohol drinking session. Participation in this study consists of an initial, in-person screening appointment, 4 brief daily appointments at the research office, an alcohol drinking session at a local bar and a follow-up appointment 1-3 days after the alcohol drinking session. Participants who are found to be eligible in the screening phase will then complete a daily appointment for 4 days out of a 5-day period (i.e., there will be 1 day out of the 5 on which they will not attend an appointment). Each appointment will last 20 minutes, on average and consist of a questionnaire and computer-based cognitive task. On the day of the fourth appointment, participants will complete an alcohol drinking session. The alcohol drinking session begins at 4pm and lasts until at least midnight. Participants in this study will be young adults between the ages of 21-25, who regularly drink alcohol and are not currently seeking treatment for alcohol use. Seventy-two participants will complete this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
69

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 31, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
Last Updated

March 6, 2020

Status Verified

March 1, 2020

Enrollment Period

2.8 years

First QC Date

January 24, 2013

Last Update Submit

March 4, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peak estimated blood alcohol concentration

    During a 3-hour alcohol drinking period

Secondary Outcomes (1)

  • Number of alcoholic drinks consumed

    During a 3-hour alcohol drinking period

Other Outcomes (2)

  • Self-reported drinks per drinking day

    6- and 12-month follow-ups after alcohol drinking session

  • Self-reported frequency of heavy drinking days

    6- and 12-month follow-up after alcohol drinking session

Study Arms (1)

Young adult alcohol drinkers

Young adults between the ages of 21-25 who regularly drink alcohol

Eligibility Criteria

Age21 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy young adults between the ages of 21-25 years of ago who regularly drink alcohol and are not currently seeking treatment for alcohol.

You may qualify if:

  • Be between the ages of 21-25.
  • Be able to read English and complete study evaluations.
  • Drink alcohol on a regular basis

You may not qualify if:

  • No participant may:
  • Be seeking treatment for alcohol or other addictive behaviors or have been in inpatient or intensive outpatient treatment within the past 12 months.
  • Provide two positive breath alcohol concentration (BAC) readings (i.e., \> 0.00%) at any of the following times: in-person screening, a pre-session screening, or at the outset of an alcohol self-administration session. After participants blow their first positive BAC, they will be allowed to reschedule and participate at another time, however if they blow a second positive BAC, they will be excluded from this study and offered referrals for alcohol treatment.
  • Have positive urine screen results at the in-person screening or pre-session screening on the day of an alcohol self-administration session for opiates, cocaine, phencyclidine, amphetamines, methamphetamine, barbiturates, methadone or benzodiazepines.
  • A woman who is pregnant, nursing, or refuses to use a reliable method of birth control.
  • Fail to perform at a normative level at screening on any of the four cognitive and psychomotor tasks administered in this study. Participants must perform within two standard deviations of the mean from the samples in relevant prior studies
  • Perform computer tasks initially administered at baseline in either a random or inordinately slow fashion
  • A body mass index lower than 18.5 or greater than 35.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University School of Medicine

New Haven, Connecticut, 06519, United States

Location

Study Officials

  • Robert F Leeman, Ph.D.

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2013

First Posted

January 31, 2013

Study Start

January 1, 2013

Primary Completion

November 1, 2015

Study Completion

October 1, 2016

Last Updated

March 6, 2020

Record last verified: 2020-03

Locations